Justices Told Hatch-Waxman Patent Safe Harbor Too Narrow
Amphastar Pharmaceuticals has urged the U.S. Supreme Court to rule that the Federal Circuit's interpretation of the safe harbor provision of the Hatch-Waxman Act is "overly narrow" and puts generic manufacturers...To view the full article, register now.
Already a subscriber? Click here to view full article